United States Continuous Glucose Monitoring (CGM) Market To Surpass USD 5 Billion Valuation By 2027

January 12, 2022

As cited by the research report titled ‘United States Continuous Glucose Monitoring (CGM) Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2027’, available with MarketStudyReport, United States continuous glucose monitoring (CGM) market is estimated to exceed a valuation of USD 5 billion over 2021-2027.

Rising prevalence of diabetes coupled with introduction of advanced diabetes care devices are the major factors driving United States continuous glucose monitoring (CGM) market growth. Growing cognizance regarding the use of these devices is propelling their adoption, thereby favoring the overall industry outlook.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4102763/

For the record, continuous glucose monitoring devices are used to measure body glucose levels, instantly at any time. The data recorded using these devices is transmitted through a wireless network to receivers, which helps to keep a track of glucose levels over a certain period.

A comprehensive assessment of the market segmentation and geographical scope is included in the document for broader perspective of this business sphere. All the segments are individually examined with respect to important aspects like production, consumption, and growth rate. By doing so, the report identifies the major avenues for stakeholders to invest their resources for amplifying profits.

The research literature incorporates a detailed assessment of the past and present trends of the industry and estimation of the market size over the analysis timeframe. It also identifies the major restraints and limitations, along with solutions for the same.

The market report presents in-depth analysis of competitive terrain by focusing on the performance of the major participants in the industry. Major players swaying the United States continuous glucose monitoring industry dynamics are Senseonics Holdings Inc., Medtronic plc, Dexcom Inc., and Abbott Laboratories.

The competitive landscape section also compiles a data on latest mergers & acquisitions, agreements, collaborations, and partnerships. By explaining the aspects, the report recommends various strategies to assist stakeholders in reducing their costs, developing contingency plans, and subsequently garnering strong returns.

Chat with us